共 50 条
- [22] Autologous Stem Cell Mobilization in the Age of Plerixafor CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (07): : 411 - 416
- [23] Economic Evaluation of Plerixafor for Stem Cell Mobilization AMERICAN JOURNAL OF MANAGED CARE, 2012, 18 (01): : 33 - 41
- [25] Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34+ peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (03) : 410 - 415
- [28] Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization Bone Marrow Transplantation, 2006, 38 : 189 - 196
- [29] Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery JOURNAL OF HEMATOTHERAPY, 1997, 6 (01): : 13 - 19
- [30] Addition of Plerixafor to Mobilization Regimens in Autologous Peripheral Blood Stem Cell Transplants Does Not Affect the Correlation of Preharvest Hematopoietic Precursor Cell Enumeration with First-Harvest CD34+ Stem Cell Yield BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (12) : 1867 - 1875